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Previously, ethanol and the protein kinase C (PKC) activators phorbol 12-myristate 13-acetate (PMA) and bombesin were shown to synergistically 
stimulate phospholipase C (PLC)-mediated hydrolysis of phosphatidylethanolamine (PtdEtn) in NIH 3T3 fibroblasts. Here we used fibroblasts 
overexpressing PKC-& 15-fold to examine the possible role of this enzyme in the regulation of PtdEtn hydrolysis by ethanol. Overexpressed PKC-E 
(i) greatly enhanced the stimulatory effects of ethanol (37.5-150 mM) on PLC-mediated PtdEtn hydrolysis, and (ii) eliminated the need for the 
co-presence of a PKC activator for maximal (3.3-fold) stimulation of PLC by 150 mM ethanol. Results suggest hat PKC-a is a potential positive 
regulator of the PtdEtn-hydrolyzing PLC activity, and that the functional interaction between PKC-.Z and PLC is facilitated by ethanol. 
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1. INTRODUCTION regulation of PLC activity by another PKC isozyme 
different from PKC-a. 
Work in our laboratory has revealed two specific 
effects of ethanol on the hydrolysis of phosphatidyl- 
ethanolamine (PtdEtn) in NIH 3T3 fibroblasts. In the 
presence of an activator of protein kinase C (PKC), 
such as phorbol 12-myristate 13-acetate (PMA), ethanol 
was found to rapidly, but only transiently, enhance 
phospholipase D-mediated hydrolysis of PtdEtn [ 11. Be- 
cause this co-stimulatory effect of ethanol is transient, 
presently we cannot assign any possible (patho)phys- 
iological role for this process. More importantly, etha- 
nol also exerts a longer-term stimulatory effect on phos- 
pholipase (PLC)-mediated PtdEtn hydrolysis [2]. Al- 
though this latter ethanol effect starts only after a 20-30 
min lag period, it lasts for several hours causing signif- 
icant decreases in the cellular content of PtdEtn [2]. 
Since PtdEtn is a major phospholipid in the cytoplasmic 
leaflet of plasma membrane, a reduction in its cellular 
content by activated PLC may contribute to the media- 
tion of biological effects of ethanol. Hence, our interest 
in this phenomenon. 
NIH 3T3 fibroblasts contain only the c1-, E-, and c- 
PKC isozymes in detectable amounts ([3]; and our un- 
published observations). Since PKC-a negatively regu- 
lates PLC activity [2] and PKC-C does not interact with 
PMA [4-71, PKC-E appeared to be the most likely can- 
didate to mediate the synergistic stimulatory effects of 
ethanol and PMA on PLC-mediated PtdEtn hydrolysis. 
Here we examined this possibility in NIH 3T3 fibro- 
blasts overexpressing PKC-E about 15-fold. We show 
that overexpressed PKC-E potentiates the stimulatory 
effect of ethanol on PLC-mediated PtdEtn hydrolysis. 
2. EXPERIMENTAL 
2.1. Materials 
Interestingly, while PMA alone inhibited PLC-medi- 
ated PtdEtn hydrolysis by a PKC-&-mediated process, 
it enhanced the stimulatory effect of ethanol on this 
PLC activity [2]. This would be consistent with positive 
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Abbreviations: PKC, protein kinase C; PMA, phorbol 12-my&ate 
13-acetate; PtdEtn, phosphatidylethanolamine; PLC, phospholipase 
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PMA, Dowex-SOW(H’ form), phenyhnethylsulfonyl fluoride (PMSF), 
leupeptin, and aprotinin were purchased from Sigma; biotinylated 
goat anti-rabbit IgG, streptavidin-alkaline phosphatase conjugate, ni- 
troblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phos- 
phate were bought from Boehringer-Mannheim. Polyclonal antibod- 
ies raised against he a-, c-, and E-PKC isozymes were kindly donated 
by Dr. Y.A. Hannun (Duke University, Durham, NC, USA); [2- 
“C]ethanolamine (50 mCi/mmol) was from Amersham; the pSPORT 
I plasmid, tissue-culture reagents, and the lipofection transfection kit 
were bought from Gibco BRL; the restriction endonucleases SmaI, 
EarI, ALW NI, and BsmI were bought from New England Biolabs; 
the restrictive ndonucleases HindIII, ALW 261, and CIaI were from 
Promega; the pcDNA 3 expression vector was from Invitrogene. 
2.2. Cell culture 
The NIH 3T3 clone-7 fibroblast line was provided by Dr. D.R. 
Lowy (National Cancer Institute, NIH, Bethesda, MD, USA). The 
fibroblasts were continuously cultured in Dulbecco’s modified Eagle’s 
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medium supplemented with 10% (v/v) fetal calf serum, penicillin (50 
units/ml), streptomycin (50 fig/ml) and glutamine (2 mM). 
2.3. Generation of PKC-E overexpressing cell line 
The PKC-.s/pTB 803 pLTR-based cDNA clone, expressing full- 
length rat PKC-E [8], was a generous gift from Dr. Yositaka Ono 
(Kobe University, Kobe, Japan). The original pTB 803 plasmid was 
changed to contain the neomycin resistant gene derived from the 
pcDNA 3 expression vector. In this vector, the neomycin resistance 
gene is driven by the SV,, promotor-origo complex; using Hind111 and 
SmaI, the SV, complex was replaced by a bacterial promoter sequence 
present in pSPORT I plasmid by using the ALW 261 and Ear1 restric- 
tion endonucleases. The neomycin resistance gene from this construct 
was cloned into the ClaI site of pTB 803 clone by using the ALW NI 
and BsmI restriction endonucleases. NIH 3T3 fibroblasts were trans- 
fected with either empty vector as a control, or with the PKC-& expres- 
sion vector using lipofection, following the procedure recommended 
by the manufacturer (Gibco BRL). The transfected cells were subse- 
quently grown for 10 days in complete Dulbecco’s medium containing 
900 pg/ml neomycin, and then for 16 days in the presence of 600 &ml 
neomycin. After 26 days in selection medium, single colonies were 
picked and examined for the presence of PKC-& by Western blot 
analysis. Vector control cells (NIH 3T3/PKC-e,) and one clone over- 
expressing PKC-c about 15-fold (NIH 3T3/PKC-E,,) were used in 
most experiments to determine PLD-mediated hydrolysis of PtdEtn. 
2.4. Western Blot analysis of PKC isozymes 
Attached NIH 3T3 cells (- 7&80% confluent) in 150-mm-diameter 
dishes were incubated in Dulbecco’s medium in the absence or pres- 
ence of 100 nM PMA and/or ethanol (150 mM) for 5 min. Thereafter, 
cells were scraped into 4-ml homogenization buffer containing 20 mM 
Tris-HCl, pH 7.5,50 mM sucrose, 1 mM PMSF, 100 pg/ml leupeptin 
and 25 &ml aprotinin. After homogenization, homogenates were 
first centrifuged at 800 x g for 6 min, and then supematants were 
centrifuged at 15,000 x g for 20 min to prepare cytosolic and particu- 
late fractions. Protein fractions (50 pg protein each) were subjected to 
8% SDS/PAGE, transferred to Immobilon-P transfer membranes 
(Millipore), and membranes were processed to visualize PKC-.s as 
described earlier [2]. Molecular masses were estimated with biotinyl- 
ated standard proteins (Bio-Rad). Relative amounts of PKC isoen- 
zymes were estimated ensitometrically, using a Hoefer GS-300 Scan- 
ning Densitometer equipped with GS-365 Data System and Hewlett 
Packard Vectra CS computer. 
2.5. Measurement of PLC-mediated hydrolysis of PtdEtn in intact NIH 
3T3 jibroblasts 
This was performed using fibroblasts prelabeled with [14C]etha- 
nolamine for 48 h as described earlier [2]. [‘4C]Ethanolamine phos- 
phate (EtnP), the product of [14C]PtdEtn hydrolysis by PLC, was 
separated from other products on Dowex-SOW(H’) columns as previ- 
ously indicated [2]. 
3. RESULTS AND DISCUSSION 
A Western blot analysis of PKC isozymes revealed 
that in the NIH 3T3 fibroblast line (clone-7) used here, 
the 01-, E-, and c-isozymes are present in detectable 
amounts, while PKC-8 is barely detectable, and the /II-, 
/I*-, and y-isozymes are not detectable at all (data not 
shown). In view of the inhibitory effect of PKC-a on 
PLC activity [2] and the inability of PKC-% to respond 
to PMA [47], we considered the possibility that the 
observed synergistic effects of ethanol and PMA on 
PLC-mediated PtdEtn hydrolysis [2] might involve 
PKC-E. Since this PLC activity is associated with mem- 
branes [2], an additional assumption was that ethanol 
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Fig. 1. Western blot analysis of PKC-& in PMA- and ethanol-treated 
NIH 3T3 fibroblasts. Treatments of fibroblasts with 0.01% dimethyl 
sulfoxide (lanes 1,2), 100 nM PMA (lanes 3,4), PMA plus 150 mM 
ethanol (lanes 5,6), or ethanol alone (lanes 7,8) were for 5 min. Lanes 
1,3,5,7 and 2,4,6,8 are soluble and particulate fractions, respectively. 
Lanes A and B are molecular size markers (indicated at the left side 
in kDa) and rat brain standards, respectively. The arrow indicates the 
position of PKC-E. 
and PMA may synergistically enhance the membrane 
content of the regulatory PKC isozyme. For these rea- 
sons, we first examined the individual and combined 
effects of ethanol and PMA on membrane translocation 
of PKC-E in normal NIH 3T3 (clone-7) fibroblasts. 
In these fibroblasts, PKC-.s is about 5-8 times less 
abundant than PKC-ol or PKC-5. In untreated fibro- 
blasts, PKC-E is almost equally distributed between the 
cytoplasmic (Fig. 1, lane 1) and membrane fractions 
(Figs. 1, lane 2). However, while PKC-E in the cytosol 
corresponds to a non-phosphorylated form (faster- 
moving band), the membrane bound form (slower-mov- 
ing band) can be labeled with 3’Pi, i.e. it represents a 
phosphorylated form (data not shown). Treatment of 
fibroblasts with 100 nM PMA for 5 min essentially 
eliminated the cytoplasmic pool of PKC-E (Fig. 1, lane 
3) with some of this enzyme redistributing to the mem- 
Fig. 2. Western blot analysis of PKC-E in vector control fibroblasts 
and in fibroblasts overexpressing PKC-E. Lanes 1,3 and 2,4 are soluble 
and particulate fractions, respectively, prepared from vector control 
fibroblasts (lanes 1,2) and from fibroblasts overexpressing PKC-& 
15-fold (lanes 3,4). ‘A’ represents rat brain standard. 
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Fig. 3. Potentiation of long-term stimulatory effect of ethanol on 
PLC-mediated PtdEtn hydrolysis by overexpressed PKC-E. Vector 
control NH-I 3T3 fibroblasts (A} and fibroblasts overexpressing PKC- 
E _ 1 S-fold (B) were labeled with [14C]ethanolamine for 48 h, followed 
by treatments of suspended fibroblasts for 2 h with 100 nM PMA as 
indicated, in the absence (0) or presence of 37.5 mM (@l, 75 mM (a), 
and 150 mM ethanol (w). The cellular content of [‘%]PtdEtn in these 
cells was in the range of 906,000-939,000 dpm/106 cells. [‘%]EtnP was 
separated from other hydrolytic produets as indicated in section 2. 
Data are the mean k S.E.M. of three incubations. Similar results were 
obtained in two other experiments. 
brane fraction (Fig. 1, lane 4). In five experiments exam- 
ined, membranes from PMA plus 150 mM ethanol- 
treated fibroblasts (Fig. 1, lane 6) contained 35 + 13% 
more PKC-E than membranes from cells treated with 
PMA, Ethanol alone increased the cytoplasmic content 
of PKC-E (Fig. 1, lane 7) at the expense of the mem- 
brane-bound form (Fig. 1, lane 8). Ethanol and PMA 
had similar synergistic effects on the membrane content 
of PKC-E after treatments for 30 min (data not shown). 
While these effects of ethanol and PMA established an 
important precondition for the regulation of PLC activ- 
ity by PKC-E, these data did not serve as proof that such 
regulation actually occurs. 
To further examine the possible regulatory role of 
PKC-e, next we used vector control fibroblasts (NIH 
3T3/PKC+; Fig. 2, lanes 1,2) and fibroblasts overex- 
pressing PKC-E (about 15-fold) in which PKC-E is pre- 
dominantly located in membranes (NIH 3T3/PKC-E,,; 
Fig. 2, lanes 3,4). In [‘4C]ethanola~ne-labeled vector 
control fibroblasts, 33.5 mM ethanol alone had no ef- 
fect on PtdEtn hydrolysis, while 75 and 150 mM con- 
centrations of ethanol stimulated PLC-mediated forma- 
tion of [14C]EtnP from [14C]PtdEtn 1.4 and 1.55-fold, 
respectively (Fig. 3A). Although in vector control cells, 
PMA (100 nM) alone inhibited PLC activity by 83%, it 
significantly enhanced the stimulatory effects of ethanol 
at each concentration employed (Fig. 3A). Overexpres- 
sion of PKC-E failed to enhance the ‘basal’ level of 
[i4C]EtnP formation, and it actually decreased the in- 
hibitory effect of PMA to 50% (Fig. 3B). However, 
overexpressed PKC-E greatly enhanced the ability of 
ethanol to stimulate PLC activity. Thus, in the absence 
of PMA, 37.5, 75 and 150 mM concentrations of etha- 
nol increased [i4C]EtnP formation 2.2-3.0- and 3.35- 
fold, respectively (Fig. 3B). Importantly, the stimula- 
tory effect of 150 mM (maximally effective concentra- 
tion) ethanol was not affected by PMA, while the effects 
of lower concentrations of ethanol were enhanced by 
PMA to approximately the same level which was 
achieved by 150 mM ethanol alone (Fig. 3B). 
In vector control fibroblasts, ethanol alone or in com- 
bination with PMA had no effect on PLC activity after 
15 min incubation (Fig. 4). In contrast, in PKC-E over- 
expressors 150 mM ethanol alone stimulated PLC-me- 
diated PtdEtn hydrolysis about 2.3-fold; this effect 
of ethanol was not significantly enhanced by PMA 
(Fig. 4). 
Measurable increase in ethanol effect (in the absence 
of PMA) on PtdEtn hydrolysis required extensive over- 
expression of PKC-8. In this work we also examined the 
effect of ethanol in two other fibroblast lines overex- 
pressing PKC-E about 3-fold and IO-fold. In the former 
line we have not observed significant increase in the 
stimulatory effect of ethanol, while lo-fold overexpres- 
sion of PKC-E approximately doubled the effects of 75 
and 150 mM concentrations of ethanol on PtdEtn hy- 
drolysis (data not shown). 
In conclusion, we showed here that overexpression of 
PKC-E in fibroblasts sensitizes the PtdEtn-hydrolyzing 
PLC system to the stimulatory effect of ethanol. In 
PKC-E overexpressors, stimulation of PLC by a maxi- 
Fig. 4. Potentiation of short-term stimulatory effect of ethanol on 
PLC-mediated PtdEtn hydrolysis by overexpressed PKC-.e. Vector 
control NIH 3T3 fibroblasts (I) and fibroblasts overexpressing PKC-& 
_ 1.5-fold (II) were labeled with [‘4Cjethanolamine for 48 h, followed by 
incubation of suspended fibroblasts for 15 min in the absence (0) or 
presence of 150 mM ethanol ), 100 nM PMA (@), or ethanol plus 
PMA (B). Data are the mean + S.E.M. of three incubations. Similar 
results were obtained in two other experiments. 
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co-addition of a PKC activator. Evidently, overex- 
pressed PKC-.s alone is not able to regulate PLC activ- 
ity. Most recently, ethanol has been reported to inhibit 
calcium-dependent PKC activity [9]. We also showed 
that PKC-a, the only calcium-dependent PKC-isozyme 
present in these fibroblasts, inhibits PLC activity [2]. 
Thus, it is possible that ethanol indirectly promotes an 
interaction between the PKC-E and PLC systems by 
inhibiting the activity of inhibitory PKC-a. Whether 
this is the case or not, it is clear that the relative amounts 
of PKC-.s and PKC-a determine organ sensitivity to the 
stimulatory effect of ethanol on PLC activity. 
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